Found 105 matching trials
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer PHASE1 This is a single-arm, multicenter, phase II study designed to evaluate the ...
Show More Location
Multiple Locations
Learn More & Join Trial
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer PHASE1 HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which spec...
Show More Location
The Second Affiliated Hospital Zhejiang University
Learn More & Join Trial
ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) PHASE2 This is an open-label, single-arm, Phase II investigator-initiated trial of...
Show More Location
The First Bethune Hospital of Jilin University
Learn More & Join Trial
T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis PHASE2 A phase II, open-label, multicenter, randomized controlled trial exploring ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors PHASE1 The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Show More Location
Usc Norris Comprehensive Cancer Center (Nccc)
Learn More & Join Trial
Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer PHASE2 This is an open-label, multicenter, single-arm Phase 2 clinical trial evalu...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors PHASE2 A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BN...
Show More Learn More & Join Trial
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma PHASE1 This phase I/II trial studies the side effects and best dose of ceritinib w...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma PHASE1 This trial will assess the MTD and RP2D of SOT102 administered as monothera...
Show More Location
Washington University School of Medicine in St. Louis
Learn More & Join Trial
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors PHASE1 The study is being conducted to explore the reasonable dosage and evaluate ...
Show More Location
Hunan Provincial Cancer Hospital
Learn More & Join Trial